BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
5.27
+0.61 (13.21%)
At close: Jun 5, 2025, 4:00 PM
5.38
+0.11 (2.09%)
After-hours: Jun 5, 2025, 7:11 PM EDT
BioLineRx Revenue
BioLineRx had revenue of $255.00K in the quarter ending March 31, 2025, a decrease of -96.28%. This brings the company's revenue in the last twelve months to $22.34M, up 91.68% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$22.34M
Revenue Growth
+91.68%
P/S Ratio
0.84
Revenue / Employee
$797,857
Employees
28
Market Cap
18.87M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BLRX News
- 6 days ago - Why Is Nano-Cap BioLineRx Stock Surging On Friday? - Benzinga
- 6 days ago - BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting - PRNewsWire
- 9 days ago - BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 16 days ago - BioLineRx to Report First Quarter 2025 Results on May 27, 2025 - PRNewsWire
- 2 months ago - BioLineRx Ltd. (BLRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioLineRx Reports 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - BioLineRx to Report 2024 Annual Results on March 31, 2025 - PRNewsWire